Tag: GMP compliance

Evaluating Ongoing Stability Program Gaps in Marketed Product Portfolios The pharmaceutical industry is driven by the need to ensure the efficacy, safety, and quality of products throughout their shelf life.…

Steps to Prepare for Regulatory Inspections of Ongoing Stability Programs In the fast-evolving pharmaceutical landscape, a robust ongoing stability program is pivotal for ensuring product efficacy and compliance. However, gaps…

Addressing Failures in Ongoing Stability Programs Due to Insufficient Protocols In the pharmaceutical industry, ongoing stability program failures present significant challenges, particularly when driven by inadequate protocols. These failures can…

Aligning Ongoing Stability with ICH and Regional Standards The pharmaceutical industry faces numerous challenges related to compliance with International Council for Harmonisation (ICH) guidelines while managing ongoing stability programs. Recognizing…

Addressing Gaps in Ongoing Stability Programs for Temperature Excursion Impact Assessment In the pharmaceutical manufacturing environment, maintaining the integrity of stability studies is vital to ensure product quality and regulatory…

Addressing Gaps in Ongoing Stability Programs Across Manufacturing Sites Managing ongoing stability programs is crucial for ensuring that pharmaceutical products meet quality standards throughout their shelf life. Companies often grapple…